✦ LIBER ✦

Clinical Efficacy and Safety of Once-Daily Dosing of a Novel, Prolonged-Release Oral Morphine Tablet Compared With Twice-Daily Dosing of a Standard Controlled-Release Morphine Tablet in Patients With Cancer Pain: A Randomized, Double-Blind, Exploratory Crossover Study

✍ Scribed by Derry Ridgway; Maciej Sopata; Arvydas Burneckis; Lillian Jespersen; Christine Andersen

Book ID: 113741784
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 289 KB
Volume: 39
Category: Article
ISSN: 0885-3924
DOI: 10.1016/j.jpainsymman.2009.08.013

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

375 EFFICACY AND SAFETY OF TWICE-DAILY D

375 EFFICACY AND SAFETY OF TWICE-DAILY DOSING OF CONTROLLED-RELEASE HYDROCODONE AND ACETAMINOPHEN TABLETS FOR MODERATE TO SEVERE OSTEOARTHRITIS PAIN: A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-COONTROLLED STUDY

✍ L. Gilderman; J. Box; B. Rankin; G. Podolsky; D. Morris; J. Thomas; E. Lockhart; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Efficacy and Safety of Fentanyl Pectin N

Efficacy and Safety of Fentanyl Pectin Nasal Spray Compared with Immediate-Release Morphine Sulfate Tablets in the Treatment of Breakthrough Cancer Pain: A Multicenter, Randomized, Controlled, Double-Blind, Double-Dummy Multiple-Crossover Study

✍ Marie Fallon; Carlo Reale; Andrew Davies; A. Eberhard Lux; Kirushna Kumar; Andrz 📂 Article 📅 2011 🏛 Frontline Medical Communications, Inc. 🌐 English ⚖ 869 KB

A Randomized, Double-Blind, Multi-Site,

A Randomized, Double-Blind, Multi-Site, Crossover, Placebo-Controlled Equivalence Study of Morning Versus Evening Once-Daily Sustained-Release Morphine Sulfate in People with Pain from Advanced Cancer

✍ David C. Currow; John L. Plummer; Neil J. Cooney; David Gorman; Paul A. Glare 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 89 KB